DoD Multiple Sclerosis, Exploration - Hypothesis Development Award | HT942524MSRPEHDA

Opportunity Information: Apply for HT942524MSRPEHDA

The DoD Multiple Sclerosis Research Program (MSRP) Exploration - Hypothesis Development Award (EHDA) is a discretionary U.S. Department of the Army grant opportunity administered through USAMRAA that is meant to fund early-stage, bold ideas in multiple sclerosis research. Its main purpose is to support the initial exploration of concepts that are innovative, high-risk, and high-gain, with the expectation that the work will generate a strong foundation for follow-on studies and future lines of scientific investigation. This mechanism is positioned for projects that may be too early or uncertain for more traditional funding routes but could be genuinely transformative if the underlying idea proves out.

A central requirement is that the application propose a well-formulated and testable hypothesis, backed by a clear scientific rationale and a solid study design. Importantly, the program does not require preliminary or published data, which signals that the sponsor is intentionally making room for hypothesis-generating or first-in-field experiments where existing evidence may be limited. That said, the absence of a preliminary data requirement does not reduce expectations for rigor; applicants still need to show that the question is logically constructed, the approach can realistically test the hypothesis, and the overall plan is methodologically sound.

Innovation is the defining feature of this award. The research must go beyond incremental extensions of existing work. Competitive projects are expected to introduce a novel paradigm, challenge current paradigms, reframe established problems from a new angle, or otherwise demonstrate a high level of creativity that could shift how MS is understood, studied, or ultimately managed. Proposals that mainly add another small step to ongoing research or closely track already published results are explicitly described as not aligning with the intent of the EHDA. Because of this, the Principal Investigator is expected to clearly and explicitly explain what makes the project innovative within the MS field, rather than assuming reviewers will infer novelty on their own.

For applications submitted under the focus area "Correlates of Disease Activity and Progression in MS," there is an added practical requirement: applicants must demonstrate access to the relevant specimens and/or data for the cohort they plan to study. The opportunity points applicants to specific documentation (letters confirming access) to substantiate that the proposed work is feasible and that the team can actually obtain the needed samples or datasets. In other words, even though the program is open to high-risk ideas, it still expects applicants to remove avoidable feasibility risks, especially around data and biospecimen availability.

The announcement also flags considerations for projects that use animal models of MS. Applicants are expected to choose models thoughtfully and to justify, in a clear and specific way, why the selected model is relevant to the particular aspect of human MS being investigated. This is a reminder that animal models vary widely in what they can and cannot represent (for example, inflammatory mechanisms versus neurodegenerative features), and the proposal should make a convincing case that the model is appropriate for the hypothesis being tested.

A notable feature is the New Investigator option, which is designed to encourage and support investigators who are in the early stages of establishing themselves in MS research and are early in their faculty appointments. The program separates Established Investigator and New Investigator applications for peer and programmatic review, which can help ensure early-career proposals are evaluated in an appropriate context. New Investigators are also encouraged to strengthen their submissions through collaboration with researchers who have MS-specific experience or other relevant expertise, particularly collaborators with demonstrated funding and publication track records. This signals that the program values promising independent leadership while also recognizing the practical benefit of mentorship and complementary expertise for ambitious, first-step projects.

From an administrative standpoint, the funding opportunity is listed as HT942524MSRPEHDA under CFDA 12.420, categorized under Science and Technology and other Research and Development, and uses the grant funding instrument. Eligibility is listed as unrestricted, indicating a broad set of applicant organizations may apply, subject to the standard terms in the full announcement. The original application closing date is October 7, 2024, and the program anticipates making about eight awards. The listing shows an award ceiling field but does not provide a numeric value in the provided source text, so applicants would need to consult the full funding announcement for budget limits, performance period details, and any cost restrictions.

Overall, this opportunity is best suited for MS researchers proposing clearly articulated, hypothesis-driven projects that take a real conceptual leap and could open up new directions for the field, especially when those ideas are still at the exploratory stage and not yet supported by extensive preliminary data. The most competitive applications will pair genuine novelty with a credible plan for testing the hypothesis, demonstrate access to any required cohorts or specimens when applicable, and make a strong case that the work is both imaginative and scientifically grounded.

• The Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Multiple Sclerosis, Exploration - Hypothesis Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on 2024-04-19.
• Applicants must submit their applications by 2024-10-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 8 candidate(s).
• Eligible applicants include: Unrestricted.

Apply for HT942524MSRPEHDA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: